Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways

Molecular Cancer Therapeutics
ShouWei Han, Jesse Roman

Abstract

Peroxisome proliferator-activated receptors gamma (PPARgamma) exert diverse effects on cancer cells. Recent studies showed that rosiglitazone, a synthetic ligand for PPARgamma, inhibits cell growth. However, the exact mechanisms underlying this effect are still being explored, and the relevance of these findings to lung cancer remains unclear. Here, we report that rosiglitazone reduced the phosphorylation of Akt and increased phosphatase and tensin homologue (PTEN) protein expression in non-small cell lung carcinoma (NSCLC) cells (H1792 and H1838), and this was associated with inhibition of NSCLC cell proliferation. These effects were blocked or diminished by GW9662, a specific PPARgamma antagonist. However, transfection with a CMX-PPARgamma2 overexpression vector restored the effects of rosiglitazone on Akt, PTEN, and cell growth in the presence of GW9662. In addition, rosiglitazone increased the phosphorylation of AMP-activated protein kinase alpha (AMPKalpha), a downstream kinase target for LKB1, whereas it decreased phosphorylation of p70 ribosomal protein S6 kinase (p70S6K), a downstream target of mammalian target of rapamycin (mTOR). Of note, GW9662 did not affect the phosphorylation of AMPKalpha and p70S6K protein. The i...Continue Reading

References

May 16, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Stamatios TheocharisAntonios Koutselinis
Jul 11, 2002·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·T SasakiK Chayama
Jan 22, 2003·Biochemical and Biophysical Research Communications·Buckminster Farrow, B Mark Evers
Feb 1, 2003·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Naoki KimuraKazuyoshi Yonezawa
Jan 20, 2004·Molecular and Cellular Biology·Krishna Murthi VasudevanVivek M Rangnekar
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shouwei HanJesse Roman
Apr 8, 2004·American Journal of Physiology. Endocrinology and Metabolism·Kei SakamotoDario R Alessi
Jun 15, 2004·The Biochemical Journal·Nick R Leslie, C Peter Downes
Jun 29, 2004·International Journal of Cancer. Journal International Du Cancer·Shouwei HanJesse Roman
Jul 3, 2004·The Lancet Oncology·Christian GrommesMichael T Heneka
Sep 11, 2004·Biochemical and Biophysical Research Communications·Xiaoqin XiangZhijun Luo
Dec 1, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Donghwa KimJin Q Cheng
Dec 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Pietro FerruzziMassimo Mannelli
Dec 14, 2004·Immunologic Research·Rahul K Patel, Chandra Mohan
Feb 1, 2005·Trends in Pharmacological Sciences·Zhijun LuoNeil B Ruderman
Feb 22, 2005·Cardiovascular Research·Maha AbdelrahmanChristoph Thiemermann
Feb 23, 2005·Prostate Cancer and Prostatic Diseases·L LiT C Thompson
Mar 23, 2005·Current Opinion in Cell Biology·D Grahame Hardie

❮ Previous
Next ❯

Citations

Aug 7, 2012·Cancer Immunology, Immunotherapy : CII·Stephanie K BuntMichael A Hollingsworth
Jan 5, 2013·Biochimica Et Biophysica Acta·S E KorsseW van Veelen
Mar 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W N WilliamH-Y Lee
Aug 11, 2012·Journal of the National Cancer Institute·Ronac MamtaniJames D Lewis
Feb 16, 2008·PPAR Research·Venkateshwar G KeshamouniJesse Roman
Sep 5, 2008·PPAR Research·Saswati HazraSteven M Dubinett
Dec 20, 2008·PPAR Research·Rosemary E Teresi, Kristin A Waite
Jul 11, 2012·PPAR Research·Ajit A KulkarniPatricia J Sime
Apr 7, 2009·American Journal of Respiratory Cell and Molecular Biology·Ming-Yue LiGeorge G Chen
Oct 17, 2012·BMC Bioinformatics·Fan Zhang, Renee Drabier
Nov 21, 2007·BMC Cancer·Yuh-Cheng YangYeou-Ping Tsao
Feb 12, 2008·BMC Cancer·Gabriela MagentaMaría Adela Jasnis
Mar 26, 2010·World Journal of Biological Chemistry·Shou Wei Han, Jesse Roman
Jul 4, 2008·PPAR Research·Elke Burgermeister, Rony Seger
Jan 23, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Huamei HeJames A Balschi
Jan 7, 2009·PPAR Research·Liliane Michalik, Walter Wahli
Jun 13, 2012·Expert Opinion on Therapeutic Targets·Alberto M MartelliJames A McCubrey
Apr 24, 2014·BioMed Research International·Chiou-Feng LinChiung-Wen Tsao
Aug 2, 2007·Expert Opinion on Therapeutic Targets·Efstathia PapageorgiouMichael Koutsilieris
May 17, 2008·PPAR Research·Christian FreudlspergerJürgen Hoffmann
Apr 1, 2008·Diabetes Care·Matteo MonamiEdoardo Mannucci
Jan 8, 2008·Surgical Oncology Clinics of North America·Volkert B Wreesmann, Bhuvanesh Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved